GLP-1 weight loss results on TikTok: what the science says

What did @analiguajardo_ actually say?

Honestly, this is a difficult video to fact-check in the traditional sense. The transcript is largely incoherent, appearing to be an auto-generated caption from a Spanish-language video that got run through unreliable speech-to-text software. What comes through is someone sharing a personal transformation, referencing how much they've changed physically, and expressing surprise at their own results. The phrase "I've never changed so much" and comparisons to how others perceive their body size suggest this is a before-and-after style testimonial, likely tied to a GLP-1 medication journey. The emotional tone is genuine. The factual content, however, is nearly impossible to extract.

The video has 88,300 views and a warm, community-focused caption. That reach matters, even when the spoken content is hard to parse. Viewers are drawing conclusions from this, whether the creator intends them to or not.

Does the science back this up?

If this is a GLP-1 weight loss testimonial, the basic premise that these medications produce significant body composition changes is well-supported. The evidence base here is genuinely strong, not hype.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that participants using semaglutide 2.4mg weekly lost an average of 14.9% of body weight over 68 weeks, compared to 2.4% in the placebo group. The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed tirzepatide users losing up to 20.9% of body weight at the highest dose. These are not trivial numbers. People on these medications often report that friends and family stop recognizing them, which aligns with what this creator seems to be describing.

Physical appearance changes of the magnitude described in this category of videos are real, documented, and reproducible in clinical settings. That part checks out.

What did they get wrong (or right)?

This is where the transcript problem becomes a genuine issue. Without understanding what was actually said in Spanish, it is not responsible to assign accuracy ratings to specific claims. The auto-generated English text includes phrases like "there's no sign of gold" and "I'm going to hire you," which are clearly translation artifacts, not actual statements.

What can be said is this: personal testimonial videos about GLP-1 medications frequently contain several categories of problematic claims. These include attributing all weight loss solely to the medication without acknowledging dietary changes, implying results are typical when they may reflect best-case outcomes, and sometimes making implicit claims about sustainability of results after stopping the drug. Research is clear on that last point. Rubino et al. (2021, Diabetes, Obesity and Metabolism) found that participants regained two-thirds of their lost weight within one year of stopping semaglutide. If this video skips that detail, it wouldn't be unusual, but it would be incomplete.

What should you actually know?

GLP-1 receptor agonists produce real, sometimes dramatic physical transformations. That is not in dispute. But a few things that rarely make it into testimonial videos deserve your attention.

• Results vary considerably based on baseline weight, adherence, dietary habits, and the specific medication and dose used.
• The medications work while you take them. Discontinuation is associated with significant weight regain in most patients (Rubino et al., 2021).
• Side effects including nausea, vomiting, gastroparesis-like symptoms, and rare but serious pancreatitis risk are real and should be discussed with a prescribing clinician, not a TikTok comment section.
• Compounded versions of semaglutide and tirzepatide are not equivalent to FDA-approved brand-name drugs. Purity, potency, and sterility standards differ. Do not treat them as interchangeable.

This creator's emotional reaction to their transformation is relatable and probably authentic. But 88,000 viewers deserve context that a 60-second testimonial can't provide.